Scott Newsome, DO, leads a panel discussion with thought leaders on the implications of findings from a recently published longitudinal [...]
Key Points Question How do patients with multiple sclerosis (MS) who have COVID-19 fare and are there patient and disease [...]
Multiple sclerosis is a common disease of unknown etiology, variable course, and undefinable prognosis for the individual (1). The [...]
Dr. John F. Kurtzke is a well-known and beloved figure in the CMSC and, of course, the man behind the scale which bears his name. His [...]
En Uruguay, la prevalencia de la Esclerosis Múltiple en el Uruguay, es la más alta de América del Sur, América Central y México [...]
There are few studies reporting multiple sclerosis prevalence rates in the Buenos Aires region, Argentina (latitude 34ºS) (between [...]
Multiple sclerosis (MS) is the most common inflammatory disease of the central nervous system. The etiology of multiple sclerosis is [...]
